Case ReportsSkin Picking Successfully Treated With Atomoxetine in Comorbid Skin Picking and Attention-Deficit/Hyperactivity Disorder: A Case ReportYurteri, Nihal MD; Sarıgedik, Enes MDAuthor Information Department of Child and Adolescent Psychiatry, Düzce University Faculty of Medicine, Düzce, Turkey. Nihal Yurteri is the first author of this article. Address correspondence and reprint requests to Nihal Yurteri, MD, Department of Child and Adolescent Psychiatry, Düzce University Faculty of Medicine, Konuralp, 81620, Düzce, Turkey; E-mail: firstname.lastname@example.org Conflicts of Interest and Source of Funding: The authors have no conflicts of interest to declare. orcid.org/0000-0002-4681-2210 orcid.org/0000-0002-9294-1152 Clinical Neuropharmacology: 7/8 2020 - Volume 43 - Issue 4 - p 114-115 doi: 10.1097/WNF.0000000000000393 Buy Metrics Abstract “Skin picking disorder” (SPD: also known as neurotic excoriation, psychogenic excoriation, or dermatillomania) is classified in the “obsessive-compulsive and related disorders” category in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, and characterized by unintentional, repetitive skin picking behaviors. Atomoxetine is a selective noradrenaline reuptake inhibitor used in the treatment of attention-deficit/hyperactivity disorder (ADHD). In this case report, we present a 9-year-old girl with the comorbid diagnosis of ADHD and SPD treated successfully with atomoxetine. To our knowledge, this is the first report of skin picking treated with atomoxetine in a patient with ADHD. We discussed possible explanations of mechanisms. Further studies are required on the effectiveness of atomoxetine for the treatment of SPD in the presence and absence of comorbid ADHD. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.